GU Oncology Now Contributors and Partners

EDITORIAL ADVISORY BOARD

EDITORS

Catherine Handy Marshall, MD, MPH, is assistant professor of oncology in the Department of Oncology-Genitourinary Cancer Disease at the Johns Hopkins University School of Medicine in Baltimore, Maryland. Both her clinical practice at the hospital and her research are focused on prostate cancer.

Jérémie Calais, MD, MSc, is director of the theranostics and clinical research programs, Ahmanson Translational Theranostics Division, and associate professor, Department of Molecular and Medical Pharmacology, at the University of California, Los Angeles. He leads a clinical research program on nuclear medicine and theranostics, combining radionuclide imaging and therapy.

ASSOCIATE EDITORS

David Ambinder, MD, is a urology resident at New York Medical College/Westchester Medical Center. His interests include surgical education, GU oncology, and advancements in technology in urology. A significant portion of his research has been focused on litigation in urology.

Akhil Abraham Saji, MD, is a urology resident at New York Medical College/Westchester Medical Center. His interests include urology education and machine learning applications in urologic care. He is a founding and current member of the EMPIRE urology lecture series developed by the American Urological Association New York section.

GU ONCOLOGY NOW EDITORIAL STAFF

SENIOR MANAGING EDITOR

Vanessa B. Ira, vira@mashupmd.com

ASSISTANT EDITOR

Emily Menendez, emenendez@mashupmd.com

ASSISTANT ART DIRECTOR

John Salesi, jsalesi@amcmediagroup.com

PARTNERS

The Uromigos

The Uromigos podcast, hosted by Thomas Powles, professor of genitourinary oncology at Barts Cancer Centre, and Brian Rini, Ingram Professor of Medicine at Vanderbilt-Ingram Cancer Center, broadcasts the latest developments in GU cancer. Each episode features fascinating discussions with leading experts from around the world and dives into the data and clinical news relevant to the care of GU oncology patients. In their “Legends of GU Oncology” series, the podcasting duo focuses on the founders of the field.